backtop


Print 10 comment(s) - last by mustaka.. on May 18 at 10:12 AM


  (Source: nlm.nih.gov)
Marshall Zhang's treatment proved to be effective on living cells

A 16-year-old high school student may have found a new, viable treatment for cystic fibrosis through the use of computer simulations 

Marshall Zhang, an 11th grade student at Richmond Hill's Bayview Secondary School in Toronto, Canada, used a supercomputer system to figure out how certain drugs react with proteins associated with cystic fibrosis. 

Cystic fibrosis is a recessive genetic disease that causes thick mucus to build up in the lungs and throughout the body causing progressive disability and even death. This disease occurs in about 1 out of 3,000 live births, and has no cure. 

Zhang grew interested in disease-related research after taking Advanced Placement Biology in the 10th grade. He wanted to work in a laboratory with real scientists, so he started getting in touch with local professors to see if he could participate in their research labs.

While many biochemistry professors at the University of Toronto rejected Zhang's idea due to his lack of experience, Dr. Christine Bear, a researcher at the Hospital for Sick Children's Research Institute in Toronto, welcomed him to her lab.  

While working at Bear's lab, Zhang utilized the Canadian SCINET supercomputing network to see how new compounds reacted to the proteins associated with cystic fibrosis. Through a series of computer simulations, he found that a combination of different drugs could be used simultaneously without impacting one another to treat cystic fibrosis. In fact, these findings were tested on living cells proved to be effective.  

"I have identified certain chemical structures that are key in the corrective effects of these molecules, as well as identified two molecular targets on the protein for future therapeutics," said Zhang.  

Zhang realizes that his discovery may not pan out once tested on humans because treatments sometimes turn out to be ineffective or even toxic. But he believes his research will be crucial to cystic fibrosis studies regardless. 

Zhang's research landed him a first place award at the 2011 Sanofi-Aventis BioTalent Challenge on Tuesday, which is a contest where students conduct research projects with mentors. 



Comments     Threshold


This article is over a month old, voting and posting comments is disabled

RE: Its sad.
By mmatis on 5/16/2011 9:50:09 AM , Rating: 3
And which of their graduate students would you have them cut to enable this student to take their place? Be careful, because if you end up cutting a Preferred Species then FedGov will be on your case. And yes, that happens in Canada as well. Heck, even the UK's "conservative" Cameron was recently railing against England's top universities for not having enough Preferred Species. Even though almost all of same did not meet even the most basic of their academic qualifications.


"I modded down, down, down, and the flames went higher." -- Sven Olsen














botimage
Copyright 2014 DailyTech LLC. - RSS Feed | Advertise | About Us | Ethics | FAQ | Terms, Conditions & Privacy Information | Kristopher Kubicki